Hypoxic and pharmacological activation of HIF inhibits SARS-CoV-2 infection of lung epithelial cells-Reference-Cited by-同舟云学术

Hypoxic and pharmacological activation of HIF inhibits SARS-CoV-2 infection of lung epithelial cells

Published:2021-04 Issue:3 Volume:35 Page:109020
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Wing Peter A.C.^ORCID,Keeley Thomas P.,Zhuang Xiaodong^ORCID,Lee Jeffrey Y.^ORCID,Prange-Barczynska Maria^ORCID,Tsukuda Senko^ORCID,Morgan Sophie B.,Harding Adam C.^ORCID,Argles Isobel L.A.^ORCID,Kurlekar Samvid^ORCID,Noerenberg Marko^ORCID,Thompson Craig P.^ORCID,Huang Kuan-Ying A.,Balfe Peter^ORCID,Watashi Koichi,Castello Alfredo,Hinks Timothy S.C.^ORCID,James William^ORCID,Ratcliffe Peter J.^ORCID,Davis Ilan,Hodson Emma J.^ORCID,Bishop Tammie^ORCID,McKeating Jane A.^ORCID

Funder

MRC

Wellcome Trust

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference54 articles.

1. Phase 3, randomized, double-blind, active-comparator (darbepoetin alfa) study of oral roxadustat in CKD patients with anemia on hemodialysis in Japan;Akizawa;J. Am. Soc. Nephrol.,2020

2. Efficacy and safety of daprodustat compared with darbepoetin alfa in Japanese hemodialysis patients with anemia: a randomized, double-blind, phase 3 trial;Akizawa;Clin. J. Am. Soc. Nephrol.,2020

3. Intermittent oral dosing of roxadustat in peritoneal dialysis chronic kidney disease patients with anemia: a randomized, phase 3, multicenter, open-label study;Akizawa;Ther. Apher. Dial.,2020

4. A Phase 3, multicenter, randomized, two-arm, open-label study of intermittent oral dosing of roxadustat for the treatment of anemia in Japanese erythropoiesis-stimulating agent-naïve chronic kidney disease patients not on dialysis;Akizawa;Nephron,2020

5. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain;Berenguer;Clin. Microbiol. Infect.,2020

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The N6-methyladenosine demethylase ALKBH5 regulates the hypoxic HBV transcriptome;PLOS Pathogens;2024-01-16

2. Absolute quantitative and base-resolution sequencing reveals comprehensive landscape of pseudouridine across the human transcriptome;2024-01-09

3. Hypoxia inducible factors inhibit respiratory syncytial virus infection by modulation of nucleolin expression;iScience;2024-01

4. Hypoxia-Inducible Factors Activator, Roxadustat, Increases Pulmonary Vascular Resistance in Rats;Physiological Days;2023-12-31

5. Targeting hypoxia-inducible factors: therapeutic opportunities and challenges;Nature Reviews Drug Discovery;2023-12-20